Suppr超能文献

抗分枝杆菌活性的一些药用植物传统上使用的部落从中央邦、印度治疗与肺结核有关的症状。

Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.

机构信息

Department of Biochemistry, National JALMA Institute for Leprosy & Other Mycobacterial Diseases (ICMR), Tajganj, Agra 282004, Uttar Pradesh, India.

Department of Biochemistry, National JALMA Institute for Leprosy & Other Mycobacterial Diseases (ICMR), Tajganj, Agra 282004, Uttar Pradesh, India.

出版信息

J Ethnopharmacol. 2018 Dec 5;227:113-120. doi: 10.1016/j.jep.2018.08.031. Epub 2018 Aug 30.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Tuberculosis (TB) is one of the highly infectious disease caused by the bacterium Mycobacterium tuberculosis (Mtb). Several medicinal plants are traditionally used by the tribal healers of some tribal pockets of Madhya Pradesh (M.P.), India in the treatment of various ailments including TB related symptoms. The information of traditional knowledge of plants is empirical lacking systematic scientific investigation.

AIM OF THE STUDY

To provide a scientific rationale for the traditional uses of some medicinal plants in treating prolonged cough, chest complaints and TB by ethnic groups in four districts of the state of M.P., India. The anti-mycobacterial activity of these plants was also investigated against multidrug-resistant (MDR) strains of Mtb. The active plant extracts were also assessed for general cytotoxicity by human monocytic leukemia cell line, THP-1 macrophages.

MATERIALS AND METHODS

Semi structured interviews and guided field-walk methods were used to gather information on medicinal plants used by the tribal traditional healers. The study was carried out in the tribal pockets of Anuppur, Mandla, Umariya and Dindori districts of M.P., India. A total of 35 plant species distributed in 22 families were selected based on folklore uses suggested by the tribal traditional healer. The ethanol extracts of plants were evaluated for anti-mycobacterial activity against Mtb H37Rv and six MDR clinical isolates of Mtb. The anti-mycobacterial activity of plants was determined in terms of minimum inhibitory concentration (MIC) using standard resazurin microtitre plate assay (REMA). The plant extracts found to be active against Mtb were further evaluated for general cytotoxicity against human THP-1 macrophages using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay. The selectivity index (SI) of active plant extracts were also calculated on the basis of MIC and cytotoxicity.

RESULTS

Out of the 35 plants, 11 plant species showed anti-mycobacterial activity with MIC ranging from 500 to 31.25 µg/mL against Mtb H37Rv. The plant extracts also exhibited anti-mycobacterial activity against six multi-drug resistant (MDR) clinical strains of Mtb isolated from sputum samples of pulmonary TB patients. In vitro cytotoxicity of active plant extracts was also assessed in human THP-1 macrophages. The IC (50% inhibitory concentration) values of most of the plant extracts on THP-1 was found to be higher than MIC values against Mtb, indicating that the THP-1 cells are not adversely affected at concentrations that are effective against Mtb. Significant anti-mycobacterial activity was observed for eleven plants viz., Alstonia scholaris (L.) R. Br., Glycyrrhiza glabra L., Holorrhena antidysentrica (Roth) Wall. exA.DC., Mallotus philippensis (Lam.) Müll. Arg., Eulophia nuda Lindl., Cocculus hirsutus (L.) Diels, Pueraria tuberosa (Willd.) DC., Cyperus rotundus L., Curcuma caesia Roxb., Sphaeranthus indicus L. and Plumbago zeylanica L. which lends support to their traditional uses.

CONCLUSION

The present investigation supports the potential role of plants used by tribal healers as our results have shown that these plants exhibit anti-mycobacterial activity in the acceptable range against Mtb. Our study clearly lends support to the traditional uses of some plants in TB related symptoms as we have found them to exhibit significant in vitro anti-TB activity. To the best of our knowledge, anti-mycobacterial activity in plants against Mtb is being reported for the first time from tribal areas of M.P., India by the current study.

摘要

民族药理学相关性

结核病(TB)是由结核分枝杆菌(Mtb)引起的高度传染性疾病之一。印度中央邦(MP)一些部落地区的部落治疗师传统上使用几种药用植物来治疗各种疾病,包括与 TB 相关的症状。有关植物传统知识的信息是经验性的,缺乏系统的科学调查。

研究目的

为印度 MP 州四个地区的民族群体用一些药用植物治疗长期咳嗽、胸部不适和 TB 提供科学依据。还研究了这些植物对耐多药(MDR)结核分枝杆菌株的抗分枝杆菌活性。还评估了活性植物提取物对人单核细胞白血病细胞系 THP-1 巨噬细胞的一般细胞毒性。

材料和方法

采用半结构式访谈和现场引导方法收集部落传统治疗师使用的药用植物信息。该研究在印度 MP 州的安纳普尔、曼德拉、乌马里亚和丁多里地区的部落地区进行。根据部落传统治疗师建议的民间用途,选择了 22 个科的 35 种植物。评估了植物的乙醇提取物对 Mtb H37Rv 和 6 株 MDR 临床分离株的抗分枝杆菌活性。使用标准 Resazurin 微量板测定法(REMA)测定最小抑菌浓度(MIC)来确定植物的抗分枝杆菌活性。对 Mtb 有活性的植物提取物进一步用人 THP-1 巨噬细胞进行一般细胞毒性评估,使用 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑(MTT)测定法。还根据 MIC 和细胞毒性计算了活性植物提取物的选择性指数(SI)。

结果

在 35 种植物中,有 11 种植物对 Mtb H37Rv 的 MIC 范围为 500 至 31.25μg/ml,具有抗分枝杆菌活性。植物提取物还对来自肺结核患者痰液样本的六株耐多药(MDR)临床结核分枝杆菌株表现出抗分枝杆菌活性。还在人 THP-1 巨噬细胞中评估了活性植物提取物的体外细胞毒性。大多数植物提取物对 THP-1 的 IC(50%抑制浓度)值高于对 Mtb 的 MIC 值,表明在对 Mtb 有效的浓度下,THP-1 细胞不会受到不利影响。11 种植物表现出显著的抗分枝杆菌活性,分别为:Alstonia scholaris(L.)R. Br.、Glycyrrhiza glabra L.、Holorrhena antidysentrica(Roth)Wall. exA.DC.、Mallotus philippensis(Lam.)Müll.Arg.、Eulophia nuda Lindl.、Cocculus hirsutus(L.)Diels、Pueraria tuberosa(Willd.)DC.、Cyperus rotundus L.、Curcuma caesia Roxb.、Sphaeranthus indicus L.和 Plumbago zeylanica L. 这支持了它们的传统用途。

结论

目前的研究支持部落治疗师使用的植物的潜在作用,因为我们的结果表明,这些植物对 Mtb 表现出可接受范围内的抗分枝杆菌活性。我们的研究清楚地支持了一些植物在与 TB 相关的症状中的传统用途,因为我们发现它们在体外具有显著的抗 TB 活性。据我们所知,这是首次从印度 MP 州的部落地区报告植物对 Mtb 的抗分枝杆菌活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验